In addition, we mined data on the sensitivity of BL and GCB-DLBCL cell lines to the pan-AKT inhibitors MK-2206 and GSK690693 from the Genomics of Drug Sensitivity in Cancer database (http://www.cancerrxgene.org/, 09-13-2018). The gene discussed is AKT1; the disease is diffuse large B-cell lymphoma.